医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
3-(6-氨基-3-甲基吡啶-2-基)苯甲酸叔丁酯 | tert-butyl 3-(6-amino-3-methylpyridin-2-yl)benzoate | 1083057-14-0 | C17H20N2O2 |
|
3-(6-喹啉)丙酸 | 3-(quinolin-6-yl)propanoic acid | 476660-20-5 | C12H11NO2 |
|
3-(6-{[1-(2,2-二氟-苯并[1,3]二氧代-5-基)-环丙烷羰基]-氨基}-3-甲基-2-吡啶)苯甲酸盐酸盐 | 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid hydrochloride | 1160221-26-0 | C24H18F2N2O5*ClH |
|
3-(5-硝基吡啶-2-基)苯甲酸 | 3-(5-nitropyridin-2-yl)benzoic acid | 864075-95-6 | C12H8N2O4 |
|
3-(5-硝基-2-噻吩)丙烯酸 | 3-(5-nitro-2-thienyl)-2-propenoic acid | 50868-70-7 | C7H5NO4S |
|
3-(5-溴噻吩-2-基)-2,5-二辛基-6-(噻吩-2-基)吡咯并[3,4-c]吡咯-1,4(2H,5H)-二酮 | 3-(5-bromothiophen-2-yl)-2,5-dioctyl-6-(thiophen-2-yl) pyrrolo[3,4-c]pyrrole-1,4 (2H, 5H)-dione | 1335015-92-3 | C30H39BrN2O2S2 |
|
3-(5-溴-2-噻吩基)-2,5-双(2-乙基己基)-2,5-二氢-6-(2-噻吩基)吡咯并[3,4-C]吡咯-1,4-二酮 | 3-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-6-(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)dione | 1308671-90-0 | C30H39BrN2O2S2 |
|
3-(5-氯-2-苯氧基苯基)-1-甲基-2,4-吡咯烷二酮 | 3-(5-chloro-2-phenoxyphenyl)-1-methylpyrrolidine-2,4-dione | 1162120-35-5 | C17H14ClNO3 |
|
3-(5-嘧啶)-2-丙炔-1-醇 | 3-(pyrimidin-5-yl)prop-2-yn-1-ol | 174456-28-1 | C7H6N2O |
|
3-(4-苯基-哌嗪-1-基)-丙酸 | 3-(4-methylpiperazin-1-yl)propanoic acid | 55480-45-0 | C8H16N2O2 |
|
3-(4-硝基苯基)-吡啶 | 3-(4'-nitrophenyl)pyridine | 4282-46-6 | C11H8N2O2 |
|
3-(4-硝基-1-氧代-1,3-二氢异吲哚-2-基)哌啶-2,6-二酮 | 3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione | 827026-45-9 | C13H11N3O5 |
|
3-(4-甲氧苯基)-3-氧代丙酸乙酯 | ethyl 4-methoxybenzoylacetate | 2881-83-6 | C12H14O4 |
|
3-(4-甲氧基苄基)-吡啶-2-羧酸 | 3-(4-methoxybenzoyl)-pyridine-2-carboxylic acid | 116060-92-5 | C14H11NO4 |
|
3-(4-甲基哌嗪基)苯甲醛 | 3-(4-methyl-1-piperazinyl)benzaldehyde | 628325-62-2 | C12H16N2O |
|
3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯胺 | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 641571-11-1 | C11H10F3N3 |
|
3-(4-甲基-1-哌嗪基)-5-(三氟甲基)苯胺 | 3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)aniline | 641571-21-3 | C12H16F3N3 |
|
3-(4-溴苯氧)-6-甲基吡啶 | 3-(4-bromophenoxy)-6-methylpyridazine | 368869-96-9 | C11H9BrN2O |
|
3-(4-溴苯基)吡啶 | 3-(4-bromophenyl)pyridine | 129013-83-8 | C11H8BrN |
|
3-(4-溴苯基)-6-氯哒嗪 | 3-(p-bromophenyl)-6-chloropyridazine | 66548-50-3 | C10H6BrClN2 |
|
3-(4-溴苯基)-3-氧杂环丁烷胺盐酸盐 | 3-(4-bromophenyl)oxetan-3-amine hydrochloride | 1349718-53-1 | C9H10BrNO*ClH |
|
3-(4-溴苯基)-2-氯喹啉 | 3-(4-Bromophenyl)-2-chloroquinoline | 85274-82-4 | C15H9BrClN |
|
3-(4-溴苄基)吡啶 | (4-bromophenyl)(pyridin-2-yl)methanone | 18453-32-2 | C12H8BrNO |
|
3-(4-溴-苯基)-异噁唑-5-羧酸乙酯 | ethyl 5-(4-bromophenyl)isoxazole-3-carboxylate | 33277-15-5 | C12H10BrNO3 |
|
3-(4-溴-苯基)-哌啶-2-酮 | 3-(4-bromophenyl) piperidin-2-one | 769944-71-0 | C11H12BrNO |
|
3-(4-溴-1H-吡唑-1-基)氮杂环丁烷-1-羧酸叔丁酯 | tert-butyl 3-(4-bromo-1H-pyrazol-1-yl)azetidine-1-carboxylate | 877399-34-3 | C11H16BrN3O2 |
|
3-(4-氯苯基)哌嗪-1-甲酸叔丁酯 | tert-butyl 3-(4-chlorophenyl)piperazine-1-carboxylate | 886767-49-3 | C15H21ClN2O2 |
|
3-(4-氯苯基)-6-苯基-N-(4-联苯基)咔唑 | 9-([1,1'-Biphenyl]-4-yl)-3-(4-chlorophenyl)-6-phenyl-9H-carbazole | 1221238-04-5 | C36H24ClN |
|
3-(4-氯代丁基)-5-氰基吲哚 | 3-(4-chlorobutyl)-5-cyanoindole | 143612-79-7 | C13H13ClN2 |
|
3-(4-氯丁酰基)-1H-吲哚-5-甲腈 | 3-(4-chlorobutanoyl)-1H-indole-5-carbonitrile | 276863-95-7 | C13H11ClN2O |
|
3-(4-氯-2-氟-5-巯基苯基)-1-甲基-6-(三氟甲基)嘧啶-2,4(1H,3H)-二酮 | 3-(4-chloro-2-fluoro-5-sulfanylphenyl)-1-methyl-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione | 353292-92-9 | C12H7ClF4N2O2S |
|
3-(4-氨基苯基)哌啶-2,6-二酮 | 3-(4-aminophenyl)piperidine-2,6-dione | 92137-90-1 | C11H12N2O2 |
|
3-(4-氨基吡啶-3-基)丙烯酸脂 | 3-(4-Amino-3-pyridinyl)-2-propenoic acid | 773132-83-5 | C8H8N2O2 |
|
3-(4-氨基-5-溴吡啶-3-基)丙烯酸乙酯 | Ethyl 3-(4-amino-5-bromo-3-pyridyl)acrylate | 912760-87-3 | C10H11BrN2O2 |
|
3-(4-氨基-1H-吡唑-1-基)氮杂丁烷-1-羧酸叔丁酯 | tert-butyl 3-(4-amino-1H-pyrazol-1-yl)azetidine-1-carboxylate | 1029413-51-1 | C11H18N4O2 |
|
3-(4-氟苯氧基)丙酸 | 3-(4-fluoro-phenoxy)propionic acid | 1579-78-8 | C9H9FO3 |
|
3-(4-氟苯基酮)基-1-溴-4-氯苯基 | (5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone | 915095-85-1 | C13H7BrClFO |
|
3-(4-氟苯基氨基)-3-氧代丙酸 | 3-((4-fluorophenyl)amino)-3-oxopropanoic acid | 95262-10-5 | C9H8FNO3 |
|
3-(4-氟苯基)-1H-吡唑-4-羧酸甲酯 | Methyl 3-(4-fluorophenyl)pyrazolidine-4-carboxylate | 1017784-36-9 | C11H13FN2O2 |
|
3-(4-氟苯基)-1H-吡唑 | 3-(4-fluorophenyl)-1H-pyrazole | 154258-82-9 | C9H7FN2 |
|
3-(4-嘧啶-2-哌嗪)-1-丙胺 | 4-(2-pyrimidinyl)-1-piperazinepropanamine | 57648-83-6 | C11H19N5 |
|
3-(4-嘧啶)苯甲酸甲酯 | 3-pyrimidin-4-yl-benzoic acid methyl ester | 168619-01-0 | C12H10N2O2 |
|
3-(4-吡啶基)-3-氧代丙酸甲酯 | methyl 3-oxo-3-(pyridin-4-yl)propanoate | 829-45-8 | C9H9NO3 |
|
3-(4-二甲氨苯基)-3-(1-丁基-2-甲基-吲哚-3基)-6-二甲氨基苯酞 | 1(3H)-Isobenzofuranone,3-(1-butyl-2-methyl-1H-indol-3-yl)-6-(dimethylamino)-3-[4-(dimethylamino)phenyl]- | 92453-31-1 | C31H35N3O2 |
|
3-(4-(甲基氨基)-3-硝基-N-(吡啶-2-基)苯甲酰氨基)丙酸乙酯 | ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate | 429659-01-8 | C18H20N4O5 |
|
3-(4,6二甲氧基嘧啶-2-基)丙酸 | 3-(4,6-Dimethoxypyrimidin-2-yl)propanoic acid | 386715-41-9 | C9H12N2O4 |
|
3-(4,6-二甲基-2-氧代-2H-嘧啶-1-基)-丙酸 | 3-(4,6-Dimethyl-2-oxo-2H-pyrimidin-1-yl)-propionic acid | 764642-23-1 | C9H12N2O3 |
|
3-(4,5-二氢-3-甲基-5-氧代-1H-吡唑-1-基)苯甲酸 | 3-(3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid | 60297-63-4 | C11H10N2O3 |
|
3-(4,4-二甲基-4,5-二氢-1,3-噁唑)-4-甲基吡啶 | 3-(4',4'-dimethyl-4',5'-dihydro-oxazol-2'-yl)-4-methylpyridine | 68981-84-0 | C11H14N2O |
|
3-(4,4,5,5-四甲基-[1,3,2]二氧杂环戊硼烷-2-基)丙酸乙酯 | ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate | 302577-73-7 | C11H21BO4 |
|